Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA | |
Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs) Release Date: | Education | Oncology | USA | |
Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) | Education | Oncology | USA | |
Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities Release Date: | Education | Inflammation & Immunology | USA | |
Antimicrobial Stewardship in the Sub-Saharan African Region Release Date: Partner: International Society for Infectious Diseases | Quality Improvement | Inflammation & Immunology | All |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Improvement of Treatment Environment for Advanced / Recurrent Breast Cancer Release Date: | Education | Oncology | Japan | |
Improving RCC Patient Outcomes Release Date: | Education | Oncology | France, Germany, Italy, Spain, USA, United Kingdom | |
Biomarker Testing / Lung Cancer Release Date: | Education | Oncology | Japan | |
Employment support / Lung Cancer Release Date: | Education | Oncology | Japan | |
Immunotherapy in Urothelial Carcinoma | Education | Oncology | All | |
Pre-clinical and Translational Research in Multiple Myeloma Release Date: | Research | Oncology | Italy | |
PARP-inhibitor Combination Treatments in Prostate Cancer Release Date: | Education | Oncology | USA | |
Knowledge Gaps in Updated Adult Pneumococcal Immunization Recommendations Release Date: | Education | Vaccines | USA | |
Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic Diseases Release Date: Partner: The Japan College of Rheumatology | Quality Improvement | Inflammation & Immunology | Japan | |
COVID-19 Vaccine Development for LMICs Release Date: | Research | Vaccines | All | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers Release Date: | Quality Improvement | Rare Disease | USA | |
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | USA |